M E Roland

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Seroconversion following nonoccupational postexposure prophylaxis against HIV
    Michelle E Roland
    Positive Health Program at San Francisco General Hospital, California, USA
    Clin Infect Dis 41:1507-13. 2005
  2. ncbi request reprint Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure
    M E Roland
    University of California at San Francisco, Div of AIDS, Dept of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    J Infect Dis 184:1608-12. 2001
  3. ncbi request reprint Review of solid-organ transplantation in HIV-infected patients
    Michelle E Roland
    Department of Medicine, University of California, San Francisco, California, USA
    Transplantation 75:425-9. 2003
  4. ncbi request reprint Postexposure prophylaxis after sexual exposure to HIV
    Michelle E Roland
    Positive Health AIDS Program at San Francisco General Hospital, University of California, San Francisco, California 94110, USA
    Curr Opin Infect Dis 20:39-46. 2007
  5. ncbi request reprint Solid organ transplantation is a reality for patients with HIV infection
    Michelle E Roland
    Department of Medicine, University of California, Positive Health Program AIDS Division at San Francisco General Hospital, Ward 84, Building 80, 995 Potrero Avenue, San Francisco, CA 94110, USA
    Curr HIV/AIDS Rep 3:132-8. 2006
  6. ncbi request reprint Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients
    Michelle E Roland
    Positive Health Program Department of Medicine University of California, San Francisco Ward 84, San Francisco General Hospital 995 Potrero Ave San Francisco, CA 94110, USA
    Arch Intern Med 163:1773-8. 2003
  7. ncbi request reprint Kidney and liver transplantation in HIV-infected patients: case presentations and review
    Michelle E Roland
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    AIDS Patient Care STDS 17:501-7. 2003
  8. ncbi request reprint HIV RNA testing in the context of nonoccupational postexposure prophylaxis
    Michelle E Roland
    Positive Health Program at San Francisco General Hospital, Department of Medicine, University of California, San Francisco, CA 94110, USA
    J Infect Dis 190:598-604. 2004
  9. ncbi request reprint Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study
    J O Kahn
    Positive Health Program, Dept of Medicine, University of California San Francisco, at San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 183:707-14. 2001
  10. ncbi request reprint HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes
    M E Roland
    University of California, San Francisco, CA, USA
    Am J Transplant 8:355-65. 2008

Research Grants

  1. The Social Context of HIV Post-Exposure Prophylaxis
    Michelle Roland; Fiscal Year: 2006

Detail Information

Publications28

  1. ncbi request reprint Seroconversion following nonoccupational postexposure prophylaxis against HIV
    Michelle E Roland
    Positive Health Program at San Francisco General Hospital, California, USA
    Clin Infect Dis 41:1507-13. 2005
    ..We sought to describe the occurrence and circumstances of HIV seroconversion following nonoccupational PEP...
  2. ncbi request reprint Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure
    M E Roland
    University of California at San Francisco, Div of AIDS, Dept of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    J Infect Dis 184:1608-12. 2001
    ..The treatment history, particularly nonuse of a class of antiretroviral drugs, can be used to predict drug resistance...
  3. ncbi request reprint Review of solid-organ transplantation in HIV-infected patients
    Michelle E Roland
    Department of Medicine, University of California, San Francisco, California, USA
    Transplantation 75:425-9. 2003
  4. ncbi request reprint Postexposure prophylaxis after sexual exposure to HIV
    Michelle E Roland
    Positive Health AIDS Program at San Francisco General Hospital, University of California, San Francisco, California 94110, USA
    Curr Opin Infect Dis 20:39-46. 2007
    ....
  5. ncbi request reprint Solid organ transplantation is a reality for patients with HIV infection
    Michelle E Roland
    Department of Medicine, University of California, Positive Health Program AIDS Division at San Francisco General Hospital, Ward 84, Building 80, 995 Potrero Avenue, San Francisco, CA 94110, USA
    Curr HIV/AIDS Rep 3:132-8. 2006
    ..Because important patient selection and clinical management questions remain, it is critical that ongoing studies are completed quickly...
  6. ncbi request reprint Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients
    Michelle E Roland
    Positive Health Program Department of Medicine University of California, San Francisco Ward 84, San Francisco General Hospital 995 Potrero Ave San Francisco, CA 94110, USA
    Arch Intern Med 163:1773-8. 2003
  7. ncbi request reprint Kidney and liver transplantation in HIV-infected patients: case presentations and review
    Michelle E Roland
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    AIDS Patient Care STDS 17:501-7. 2003
    ....
  8. ncbi request reprint HIV RNA testing in the context of nonoccupational postexposure prophylaxis
    Michelle E Roland
    Positive Health Program at San Francisco General Hospital, Department of Medicine, University of California, San Francisco, CA 94110, USA
    J Infect Dis 190:598-604. 2004
    ..The specificity and positive predictive value of human immunodeficiency virus (HIV) RNA assays have not been evaluated in the setting of postexposure prophylaxis (PEP)...
  9. ncbi request reprint Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study
    J O Kahn
    Positive Health Program, Dept of Medicine, University of California San Francisco, at San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 183:707-14. 2001
    ..PEP, after nonoccupational HIV exposure, is feasible for persons at risk for HIV infection...
  10. ncbi request reprint HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes
    M E Roland
    University of California, San Francisco, CA, USA
    Am J Transplant 8:355-65. 2008
    ....
  11. ncbi request reprint Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients
    L A Frassetto
    Department of Medicine, Clinical Research Center, University of California, San Francisco, CA, USA
    Am J Transplant 7:2816-20. 2007
    ..Changes in antiretroviral therapy should be carefully managed to avoid insufficient immunosuppression or toxicity due to drug interactions...
  12. pmc Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients
    C S Coffin
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 10:1268-75. 2010
    ..Combination HBIG and antivirals is effective as prophylaxis with no clinical evidence of HBV recurrence but low-level HBV DNA is detectable in approximately 50% of recipients...
  13. ncbi request reprint Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients
    J T Carter
    Department of Surgery, University of California, San Francisco, California, USA
    Am J Transplant 6:753-60. 2006
    ....
  14. ncbi request reprint Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients
    P G Stock
    Department of Surgery, University of California, San Francisco, CA
    Am J Transplant 14:1136-41. 2014
    ..Future studies of sirolimus as a reservoir-modifying agent are warranted...
  15. ncbi request reprint Solid organ transplantation: referral, management, and outcomes in HIV-infected patients
    Michelle E Roland
    University of California, San Francisco, USA
    AIDS Read 16:664-8, 675-8. 2006
    ..Timely referral for transplant evaluation will prevent unnecessary mortality during the pre-transplant evaluation process...
  16. ncbi request reprint Responding to organ failure in HIV-infected patients
    Michelle E Roland
    AIDS Division, Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, USA
    N Engl J Med 348:2279-81. 2003
  17. ncbi request reprint A model for communitywide delivery of postexposure prophylaxis after potential sexual exposure to HIV
    Michelle E Roland
    Sex Transm Dis 34:294-6. 2007
  18. ncbi request reprint Evolving clinical strategies for transplantation in the HIV-positive recipient
    Peter G Stock
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Transplantation 84:563-71. 2007
    ..This overview will describe the evolving clinical strategies that have resulted in good outcomes after solid organ transplantation in the HIV-positive recipient...
  19. ncbi request reprint Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study
    Peter G Stock
    Department of Surgery, Division of Transplantation, University of California, San Francisco, California 94143 0780, USA
    Transplantation 76:370-5. 2003
    ....
  20. ncbi request reprint Enhancing the potential benefits of HIV post-exposure prophylaxis
    Michelle E Roland
    AIDS 20:1889-90. 2006
  21. ncbi request reprint Liver transplantation in HIV-infected recipients
    Michelle E Roland
    Department of Medicine, Positive Health Program, AIDS Division, University of California, San Francisco, CA, USA
    Semin Liver Dis 26:273-84. 2006
    ....
  22. ncbi request reprint Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation
    Norah A Terrault
    Department of Medicine, University of California at San Francisco, San Francisco, CA 64143 0538, USA
    Liver Transpl 12:801-7. 2006
    ..In HIV-HBV coinfected patients undergoing LT, HBV recurrence is successfully prevented with combination prophylaxis using HBIG and antivirals...
  23. ncbi request reprint Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus
    Steven D Pinkerton
    Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI 53202, USA
    Arch Intern Med 164:46-54. 2004
    ....
  24. ncbi request reprint Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients
    Lynda Frassetto
    Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
    Transplantation 80:13-7. 2005
    ....
  25. ncbi request reprint [Comprehensive guidelines translate research findings into clinical policy for HIV-infected transplant candidates and recipients]
    Michelle E Roland
    Enferm Infecc Microbiol Clin 23:331-4. 2005
  26. ncbi request reprint Solid-organ transplantation in HIV-infected patients in the potent antiretroviral therapy era
    Michelle E Roland
    University of California Positive Health Program HIV AIDS Division, San Francisco General Hospital, San Francisco, CA, USA
    Top HIV Med 12:73-6. 2004
    ..This article summarizes a presentation by Michelle E. Roland, MD, at the February and April 2004 International AIDS Society-USA courses in Atlanta, Los Angeles, and Chicago...
  27. ncbi request reprint Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior
    Jeffrey N Martin
    Department of Epidemiology and Biostatistics, the Center for AIDS Prevention Studies, and San Francisco, California 94105, USA
    AIDS 18:787-92. 2004
    ..The effectiveness of postexposure prophylaxis (PEP) following occupational exposure to HIV has prompted advocacy for PEP following sexual or drug-use exposures...
  28. ncbi request reprint Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States
    Steven D Pinkerton
    Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53202, USA
    AIDS 18:2065-73. 2004
    ..To evaluate the cost-effectiveness of HIV postexposure prophylaxis (PEP) following sexual or injection-related exposures in 96 metropolitan statistical areas in the United States (MSA)...

Research Grants2

  1. The Social Context of HIV Post-Exposure Prophylaxis
    Michelle Roland; Fiscal Year: 2006
    ..abstract_text> ..